COCA COLA CO(KO)— Stock Profile, AI Score & Financials
Consumer Staples · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
COCA COLA CO (KO) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores KO at 69.5/100 on a 32-signal composite quality model, placing it at rank #265 of 2,960 stocks — the top 10% of the AI-ranked universe. KO scores in the top quartile across revenue scale (96.9), balance sheet strength (88.0), profitability (86.8). Areas of concern include revenue growth (36.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), COCA COLA CO reports quarterly revenue of $12.5B, net income of $3.9B, an operating margin of 34.9%. Top institutional holders of KO by reported 13-F value include BERKSHIRE HATHAWAY, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. KO trades on the NYSE exchange and files with the SEC under CIK 21344. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COCA COLA CO directly from SEC EDGAR.
AI Quality Score
69.5/100
AI Rank
#265
Revenue
$12.5B
Net Income
$3.9B
Free Cash Flow
$1.8B
Operating Margin
34.9%
KO key financials by period
COCA COLA CO reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$47.9B
$13.1B
28.7%
FY 2024
10-K
$47.1B
$10.6B
21.2%
FY 2023
10-K
$45.8B
$10.7B
24.7%
FY 2022
10-K
$43.0B
$9.5B
25.4%
FY 2021
10-K
$38.7B
$9.8B
26.7%
FY 2020
10-K
$33.0B
$7.7B
27.3%
Institutions holding KO
Institutional investors reporting a position in COCA COLA CO on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-07-29 — Q2 FY2026 (quarter ended July 3, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Net operating revenues rose 7% to $13,380 million on 4% concentrate sales volume growth and favorable price/mix, lifting operating income 9% to $4,672 million.
Biggest Revenue Drivers
North America$5,405M+7%
Volume +3% and favorable pricing initiatives; unit case volume up 3% including 5% Trademark Coca-Cola growth
EMEA$3,087M+2%
Favorable pricing initiatives including inflationary pricing, partially offset by unfavorable mix and the Nigeria finished product divestiture (-3%)
Biggest Revenue Drivers
Total revenue: $13,380M+7%
North America$5,405M+7%
Volume +3% and favorable pricing initiatives; unit case volume up 3% including 5% Trademark Coca-Cola growth
EMEA$3,087M+2%
Favorable pricing initiatives including inflationary pricing, partially offset by unfavorable mix and the Nigeria finished product divestiture (-3%)
Latin America$1,839M+16%
Favorable pricing initiatives including inflationary pricing plus an 11% favorable foreign currency impact
Bottling Investments$1,525M+8%
Unit case volume up 8%, favorable mix and pricing, partially offset by India refranchising (-2%)
Asia Pacific$1,487M+1%
Volume +11% almost entirely offset by 9% unfavorable price/mix from mix and affordability initiatives
Largest Expense Items
Cost of goods sold$4,965Mvs $4,714M prior-year quarter
Higher commodity costs, partially offset by pricing initiatives and the sale of Nigeria finished product operations
Selling, general and administrative expenses$3,720M+7%
Increased marketing spending partly due to timing; currency added 1%; offset by lower annual incentive expense
Increased marketing spending, partly a timing shift within the year
Other operating charges$23Mvs $71M prior-year quarter
$9M refranchising indemnification, $6M North America modernization, $5M tax litigation, $3M BodyArmor noncompete amortization
Margins: Gross margin rose to 62.9% from 62.4% on pricing initiatives, currency and the Nigeria divestiture, partly offset by higher commodity costs. Operating margin improved to 34.9% from 34.1%.
Watch Items from the Filing
IRS transfer pricing dispute: $6.0B deposit paid plus $514M accrued interest at risk; potential additional $14B tax and interest for 2010-2025.
BodyArmor trademark carrying value $2,440M after a $960M Q4 2025 impairment; fair value now approximates carrying value, so further impairment is likely if results miss.
Asia Pacific price/mix was negative 9% on unfavorable mix and affordability initiatives, holding revenue growth to 1% despite 11% volume growth.
Ransomware event at fairlife U.S. operations temporarily suspended production; company believes the incident is not reasonably likely to have a material impact.
Africa bottling operations held for sale to CCHBC ($5,438M assets, $2,442M liabilities); Q2 gain of $66M reduced the prior $1,274M impairment.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
